-
the following or be willing to learn the following: CRISPR/Cas9 technology, metabolomics, cell culture, DNA recombinant methods and plasmid cloning, imaging and quantitative analyses, biochemistry including
-
the diagnostic data potential from minimally invasive diagnostics using highly sensitive methylation platform technologies. We study the fundamental characteristics of and create quantitative models for cell-free
-
technologies. We study the fundamental characteristics of and create quantitative models for cell-free nucleic acids (DNA) as a data-rich marker for medical diagnostics. We also have a tradition of engineering
-
duties may also be assigned. DESIRED QUALIFICATIONS: Ph.D. in Biology, Biochemistry, Biophysics, Genetics, Bioengineering, Developmental Biology, or related life science field is preferred. Highly
-
biochemistry or structural biology with prior experience and expertise in recombinant protein expression in insect cells (baculovirus), mammalian cells, and microbes. Proficiency with the development